Elucidating the toxic effect and disease mechanisms associated with Lyso-Gb3 in Fabry disease

Hum Mol Genet. 2023 Jul 20;32(15):2464-2472. doi: 10.1093/hmg/ddad073.

Abstract

Fabry disease stems from a deficiency of alpha-galactosidase and results in the accumulation of globotriaosylceramide (Gb3). However, the production of its deacylated form globotriaosylsphingosine (lyso-Gb3) is also observed and its plasma levels have closer association with disease severity. Studies have shown that lyso-Gb3 directly affects podocytes and causes sensitisation of peripheral nociceptive neurons. However, little is understood of the mechanisms of this cytotoxicity. To study the effect on neuronal cells, we incubated SH-Sy5y cells with lyso-Gb3 at low (20 ng/mL) and high (200 ng/mL) levels, to mimic mild and classical FD serum levels. We used glucosylsphingosine as a positive control to determine specific effects of lyso-Gb3. Proteomic analyses revealed that cellular systems affected by lyso-Gb3 included cell signalling particularly protein ubiquitination and protein translation. To confirm ER/proteasome perturbations, we performed an immune enrichment of ubiquitinated proteins and demonstrated specific increased protein ubiquitination at both doses. The most ubiquitinated proteins observed included the chaperone/heat shock proteins, cytoskeletal proteins and synthesis/translation proteins. To detect proteins that interact directly with lyso-Gb3, we immobilised lyso-lipids, then incubated them with neuronal cellular extracts and identified bound proteins using mass spectrometry. Proteins that specifically bound were chaperones and included HSP90, HSP60 and the TRiC complex. In conclusion, lyso-Gb3 exposure affects pathways involved in protein translation and folding. This response is observed as increased ubiquitination and changes in signalling proteins which may explain the multiple biological processes, particularly cellular remodelling, often associated with FD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fabry Disease* / genetics
  • Glycolipids / metabolism
  • Glycolipids / pharmacology
  • Humans
  • Neuroblastoma*
  • Proteomics
  • Sphingolipids / metabolism
  • Ubiquitinated Proteins
  • alpha-Galactosidase / genetics

Substances

  • globotriaosyl lysosphingolipid
  • Ubiquitinated Proteins
  • alpha-Galactosidase
  • Sphingolipids
  • Glycolipids